The long-term goal of this translational research program is to improve the therapeutic ratio, i.e., to increase the complication-free cure rate, of radiotherapy for the management of various cancers. This goal will be accomplished by the development of rational strategies to enhance radiation effectiveness through modulation of emerging molecular targets and by identifying potential markers for radiation response using molecular profiles derived from tissue specimens of patients enrolled onto previously funded clinical trials. The theme of this competing renewal application, """"""""Modulation and Prediction of Radiation Response of Cells and Tissues"""""""", therefore, aims at designing molecular-targeted approaches to overcome radiation resistance and to identify molecular predictors of normal tissue and tumor response to radiotherapy. The program consists of four research projects supported by three core components. Three projects investigate the mechanism and efficacy of tumor radiation sensitization by targeted molecular interventions, i.e., by transfer of novel genes, mda-7, by blockade/inhibition of EGFR or cyclooxygenase-2 (COX-2), or by antiangiogenic agents. The fourth project addresses molecular profiling of normal and malignant tissues to identify predictors and potential targets for radiation response. The core components consist of General Laboratory Support, DNA Microarray, and Administrative Services. Several investigators participate in more than one project and there are substantial scientific interactions among the projects. The proposed research program has grown due to the close collaboration among clinicians and basic scientists from many departments who have benefited from the expertise and resources available at the University of Texas M. D. Anderson Cancer Center. The proposed work is anticipated to have a significant impact on radiation oncology with regard to both basic radiobiology and clinical applications.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA006294-43
Application #
7280819
Study Section
Special Emphasis Panel (ZCA1-GRB-S (J1))
Program Officer
Stone, Helen B
Project Start
1998-03-06
Project End
2009-05-31
Budget Start
2007-06-01
Budget End
2008-05-31
Support Year
43
Fiscal Year
2007
Total Cost
$1,506,020
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Radiation-Diagnostic/Oncology
Type
Other Domestic Higher Education
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Edmondson, Elijah F; Hunter, Nancy R; Weil, Michael M et al. (2015) Tumor Induction in Mice After Localized Single- or Fractionated-Dose Irradiation: Differences in Tumor Histotype and Genetic Susceptibility Based on Dose Scheduling. Int J Radiat Oncol Biol Phys 92:829-36
Neskey, David M; Osman, Abdullah A; Ow, Thomas J et al. (2015) Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer. Cancer Res 75:1527-36
Keck, Michaela K; Zuo, Zhixiang; Khattri, Arun et al. (2015) Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes. Clin Cancer Res 21:870-81
Alsbeih, Ghazi; Brock, Williams; Story, Michael (2014) Misrepair of DNA double-strand breaks in patient with unidentified chromosomal fragility syndrome and family history of radiosensitivity. Int J Radiat Biol 90:53-9
Komaki, Ritsuko; Paulus, Rebecca; Blumenschein Jr, George R et al. (2014) EGFR expression and survival in patients given cetuximab and chemoradiation for stage III non-small cell lung cancer: a secondary analysis of RTOG 0324. Radiother Oncol 112:30-6
Cortez, Maria Angelica; Valdecanas, David; Zhang, Xiaochun et al. (2014) Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer. Mol Ther 22:1494-1503
Bhardwaj, Vikas; Cascone, Tina; Cortez, Maria Angelica et al. (2013) Modulation of c-Met signaling and cellular sensitivity to radiation: potential implications for therapy. Cancer 119:1768-75
Skinner, Heath D; Sandulache, Vlad C; Ow, Thomas J et al. (2012) TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence. Clin Cancer Res 18:290-300
Story, Michael; Ding, Liang-hao; Brock, William A et al. (2012) Defining molecular and cellular responses after low and high linear energy transfer radiations to develop biomarkers of carcinogenic risk or therapeutic outcome. Health Phys 103:596-606
Raju, Uma; Riesterer, Oliver; Wang, Zhi-Qiang et al. (2012) Dasatinib, a multi-kinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathways. Radiother Oncol 105:241-9

Showing the most recent 10 out of 99 publications